Is IVUS Useful in Lower Limb PCI?

Peripheral vascular disease is on the rise and peripheral PCI is at present the first choice of treatment for most patients. 

¿Es útil el IVUS en las angioplastias de los miembros inferiores?

The use of IVUS in femoropopliteal territory has shown great benefits, especially in left main and complex PCI, reducing mortality and restenosis but, though promising, in lower limb ischemia we have little information as regards outcomes. 

The study looked at 85649 patients undergoing PCI in Japan. 50925 (59.5%) were done using IVUS. 

Primary end point was major or minor amputation at 12 months after procedure. 

Mean age was 74 and over 70% were men. Patients receiving IVUS presented more comorbidities, dementia, interactions and received more devices (stents, DEB, and atherotome); therefore, patients were match with propensity score, which left 31534 patients in each group. 

Read also: Post PCI Angina: Inevitable or Avoidable?

Primary end point resulted in favor of the IVUS group (6.9% vs. 9.3%HR, 0.80 [95% CI, 0.72–0.89] p<0.001). Also, this populations presented lower need for CABG (2.5% vs. 4.9% HR, 0.51[95% CI, 0.44–0.60] p<0.001) and stent graft vs. Non-IVUS patients, while they did present more reintervention and readmission with no difference in mortality.

Total hospitalization cost was lower with IVUS.

Conclusion

In this retrospective study, IVUS guided peripheral PCI was associated to lower amputation risk vs. peripheral PCI not guided by IVUS. These data should be interpreted with caution given its limitations as an observational study. Further research is required for researchers to be able to confirm the use of IVUS will lead to lower amputation rates. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Amputation After Endovascular Therapy With and Without Intravascular Ultrasound Guidance: A Nationwide Propensity Score–Matched Study.

Reference: Nao Setogawa, et al. Circ Cardiovasc Interv. 2023;16:e012451. DOI: 10.1161/CIRCINTERVENTIONS.122.012451.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....